by Steve Adams | Oct 12, 2022
With a lab conversion scheduled for completion within weeks, owners of Malden’s 200 Exchange finalized leases with their first three life science and research tenants totaling nearly 100,000 square feet.
by Steve Adams | Jul 17, 2022
Corporate headquarters ribbon-cuttings attract headlines and VIPs, but developers in Burlington say early-stage biotechs will be key to expanding Boston suburbs’ newest life science cluster.
by Banker & Tradesman | Feb 27, 2022
The intense demand behind lab conversions is finally putting an end to the old ways of understanding the existing conditions of buildings. And none too soon, when liability in projects like these can be measured in millimeters.
by Steve Adams | Jan 31, 2022
A Maryland investment firm is planning to convert a 361-space parking garage into 78,000 square feet of lab space, in a submarket where asking life science rents now average $105 per square foot.
by Steve Adams | Dec 19, 2021
A newly-formed joint venture will create 352,000 square feet of lab space in Malden Center, including three spec suites.
by Steve Adams | Dec 14, 2021
A 352,000-square-foot Malden Center property will be positioned for life science uses under a newly-formed joint venture.
by Steve Adams | Oct 24, 2021
Burlington’s latest effort to build a new suburban Boston life science cluster is getting traction among developers and spurring new activity in office parks set to be repositioned with biotech at the forefront.
by Steve Adams | Sep 19, 2021
A major Medford landlord is building out spec lab suites in a 1989 office building, while another developer is proposing a speculative life science tower and city officials are reviewing zoning for taller building heights.
by Steve Adams | Apr 22, 2021
A biotech founded at University of Massachusetts Medical School is the first tenant to commit to Nan Fung Life Sciences Real Estate’s conversion of a Boston Seaport District office building into spec life science suites.
by Steve Adams | Mar 26, 2021
A $491-million loan from Blackstone Mortgage Trust will fund the acquisition and lab conversion of Charles Park One and Two in East Cambridge into life science space, according to a report.
by Steve Adams | Jan 13, 2021
San Diego-based life science developer Phase 3 Real Estate Partners has acquired a pair of properties in Watertown and South Boston for $81.2 million.
by Steve Adams | Jan 7, 2021
The $340-million acquisition of a pair of Waltham office campuses will give the new owners the opportunity to add lab-ready space for life science companies.
by Steve Adams | Jan 6, 2021
BioMed Realty is joining the procession of life science developers to Boston’s Seaport District with the acquisition of the former John Hancock corporate headquarters at 601 Congress St.
by Steve Adams | Nov 22, 2020
Boston-based Berkeley Investments has completed redevelopment of a former bank operations center into 310,000 square feet of mixed-use space.
by Steve Adams | Nov 10, 2020
Boston Properties’ suburban lab conversion strategy is gaining traction in Waltham with the signing of a 138,444-square-foot lease with a Lexington life science company.
by Steve Adams | May 12, 2019
Upgrading office and industrial buildings to lab-ready space is paying off for a growing field of developers hoping to snare the next hot biotech startup transitioning from early-stage research to commercialization.